Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere

Publication date: Apr 10, 2025

Concepts Keywords
Antivirals Binaxnow
Hours Collected
Pcr Combo
Socioeconomic Comparator
Vaccine Covid
Days
Flu
Influenza
Nasal
Participant
Participants
Pcr
Swab
Utm

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Phenylpropanolamine
pathway REACTOME Influenza Infection
disease MESH infection
disease IDO symptom
disease MESH loss of taste
disease MESH Shortness of breath
disease MESH Sore throat
disease IDO process
disease IDO site
disease MESH Influenza
drug DRUGBANK Amantadine
drug DRUGBANK Rimantadine
drug DRUGBANK Ribavirin
drug DRUGBANK Oseltamivir
drug DRUGBANK Zanamivir

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *